Skip to main content
OpenTrials

Clinical trial condition

Lung Cancer, Small Cell

Explore clinical trials studying Lung Cancer, Small Cell. Study availability and eligibility vary by location and protocol.

16 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Lung Cancer, Small Cell trial results

Completed

Trial of NanoPac Intratumoral Injection in Lung Cancer

NCT04314895

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Florida Health Gainesville, Florida, United States
  • Parkview Research Institute Fort Wayne, Indiana, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

NCT00259935

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +8 more
Locations
  • GSK Investigational Site Lebanon, New Hampshire, United States
  • GSK Investigational Site The Bronx, New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View Trial Details
Completed

The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)

NCT00043862

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +9 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fountain Valley, California, United States
View all 31 locations
View Trial Details
Completed

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

NCT00046111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +9 more
Locations
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site San Antonio, Texas, United States
View Trial Details
Completed

Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer

NCT00320359

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +8 more
Locations
  • GSK Investigational Site Bludesch, Austria
  • GSK Investigational Site Klagenfurt, Austria
  • GSK Investigational Site Linz, Austria
  • GSK Investigational Site Vienna, Austria
View all 79 locations
View Trial Details

Related conditions